These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15073697)

  • 41. Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation.
    Despotis GJ; Levine V; Joist JH; Joiner-Maier D; Spitznagel E
    Anesth Analg; 1997 Sep; 85(3):498-506. PubMed ID: 9296400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Non-Antithrombin-Mediated Heparin Resistance During Cardiac Surgery: Two Case Reports.
    Edwards JK; Sniecinski RM; Scott KJ
    A A Pract; 2019 Sep; 13(6):211-214. PubMed ID: 31162225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiopulmonary Bypass Without Heparin.
    Rehfeldt KH; Barbara DW
    Semin Cardiothorac Vasc Anesth; 2016 Mar; 20(1):40-51. PubMed ID: 26872706
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evidence-based algorithm for heparin dosing before cardiopulmonary bypass. Part 1: Development of the algorithm.
    McKinney MC; Riley JB
    J Extra Corpor Technol; 2007 Dec; 39(4):238-42. PubMed ID: 18293809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Anticoagulation management in a patient with an acquired antithrombin III deficiency.
    Heller EL; Paul L
    J Extra Corpor Technol; 2001 Dec; 33(4):245-8. PubMed ID: 11806438
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety issues in heparin and protamine administration for extracorporeal circulation.
    Jobes DR
    J Cardiothorac Vasc Anesth; 1998 Apr; 12(2 Suppl 1):17-20. PubMed ID: 9583571
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
    Pleym H; Videm V; Wahba A; Asberg A; Amundsen T; Bjella L; Dale O; Stenseth R
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):933-40. PubMed ID: 16675258
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anticoagulation management during cardiopulmonary bypass in patients with antiphospholipid syndrome.
    Seki T; Shingu Y; Sugiki H; Wakasa S; Katoh H; Ooka T; Tachibana T; Kubota S; Matsui Y
    J Artif Organs; 2018 Sep; 21(3):363-366. PubMed ID: 29541945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in heparin dose response slope during cardiac surgery: possible result in inaccuracy in predicting heparin bolus dose requirement to achieve target ACT.
    Ichikawa J; Mori T; Kodaka M; Nishiyama K; Ozaki M; Komori M
    Perfusion; 2017 Sep; 32(6):474-480. PubMed ID: 28820035
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of protamine dose on activated clotting time and thromboelastography in infants and small children undergoing cardiopulmonary bypass.
    Gautam NK; Schmitz ML; Harrison D; Zabala LM; Killebrew P; Belcher RH; Prodhan P; McKamie W; Norvell DC
    Paediatr Anaesth; 2013 Mar; 23(3):233-41. PubMed ID: 23279140
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Response of kaolin ACT to heparin: evaluation with an automated assay and higher heparin doses.
    Despotis GJ; Alsoufiev AL; Spitznagel E; Goodnough LT; Lappas DG
    Ann Thorac Surg; 1996 Mar; 61(3):795-9. PubMed ID: 8619695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The activated clotting time loading dose response ratio (ACTLORR) as an indicator of heparin demand during cardiopulmonary bypass.
    Reece IJ; Linley G; al Tareif H; DeVroege R; Tolia J; Sheth J
    Perfusion; 1996 Mar; 11(2):125-30. PubMed ID: 8740353
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coagulation and fibrinolysis system in aortic surgery under deep hypothermic circulatory arrest with aprotinin: the importance of adequate heparinization.
    Okita Y; Takamoto S; Ando M; Morota T; Yamaki F; Matsukawa R; Kawashima Y
    Circulation; 1997 Nov; 96(9 Suppl):II-376-81. PubMed ID: 9386127
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of two infusion rates of antithrombin concentrate in cardiopulmonary bypass surgery.
    Lund PE; Wassbäck G; Thomas O; Carlsson T; Schött U
    Perfusion; 2010 Sep; 25(5):305-12. PubMed ID: 20627942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical experience with the activated clotting time for the control of heparin and protamine therapy during cardiopulmonary bypass.
    Akl BF; Vargas GM; Neal J; Robillard J; Kelly P
    J Thorac Cardiovasc Surg; 1980 Jan; 79(1):97-102. PubMed ID: 7350393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of aprotinin with various anticoagulant agents in cardiopulmonary bypass.
    Terrell MR; Walenga JM; Koza MJ; Pifarré R
    Ann Thorac Surg; 1996 Aug; 62(2):506-11. PubMed ID: 8694614
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot.
    Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK
    Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Heparinless cardiopulmonary bypass revisited: a newer strategy to avoid heparin-related bleeding using dermatan sulfate.
    Brister SJ; Buchanan MR
    J Cardiothorac Vasc Anesth; 1995 Jun; 9(3):317-21. PubMed ID: 7669967
    [No Abstract]   [Full Text] [Related]  

  • 59. Aprotinin and heparin monitoring during cardiopulmonary bypass.
    Hunt BJ; Segal H; Yacoub M
    Circulation; 1992 Nov; 86(5 Suppl):II410-2. PubMed ID: 1385011
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Heparin sensitivity test for patients requiring cardiopulmonary bypass.
    DeBois WJ; Liu J; Elmer B; Ebrahimi H; Voevidko L; Lee LY; Krieger KH; Isom WW; Girardi LN
    J Extra Corpor Technol; 2006 Dec; 38(4):307-9. PubMed ID: 17312901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.